Discussion
Loading...

Post

  • About
  • Code of conduct
  • Privacy
  • Users
  • Instances
  • About Bonfire
The Japan Times
@thejapantimes@mastodon.social  ·  activity timestamp 2 weeks ago

A twice-a-year injection, recently approved for HIV prevention in the U.S. and the European Union, helps solve the problem of adherence, Gilead argues. https://www.japantimes.co.jp/business/2025/09/22/companies/gilead-twice-a-year/?utm_medium=Social&utm_source=mastodon #business #companies #hiv #medicine #gilead #pharmaceuticals #nationalhealthcare

The Japan Times

Twice-a-year injection could make HIV prevention easier, developer argues

Without the need to take a daily pill, adherence could improve, says an executive from Gilead Sciences, which developed such an injection.
  • Copy link
  • Flag this post
  • Block
Log in

bonfire.cafe

A space for Bonfire maintainers and contributors to communicate

bonfire.cafe: About · Code of conduct · Privacy · Users · Instances
Bonfire social · 1.0.0-rc.3.1 no JS en
Automatic federation enabled
  • Explore
  • About
  • Members
  • Code of Conduct
Home
Login